{"id":"https://openalex.org/W2104954969","doi":"https://doi.org/10.1124/jpet.102.036749","title":"Phase I Trial of ISIS 104838, a 2\u2032-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-\u03b1","display_name":"Phase I Trial of ISIS 104838, a 2\u2032-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-\u03b1","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2104954969","doi":"https://doi.org/10.1124/jpet.102.036749","mag":"2104954969","pmid":"https://pubmed.ncbi.nlm.nih.gov/12438559"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.102.036749","doi":"https://doi.org/10.1124/jpet.102.036749","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.102.036749","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111543477","display_name":"Kathryn Lea Sewell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Lea Sewell","raw_affiliation_strings":["Isis Pharmaceuticals Inc., Carlsbad, California 92008-7208, USA. klsewell@isisph.com","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isis Pharmaceuticals Inc., Carlsbad, California 92008-7208, USA. klsewell@isisph.com","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056554811","display_name":"Richard S. Geary","orcid":"https://orcid.org/0000-0002-6308-3179","observed_orcids":["https://orcid.org/0000-0002-6308-3179"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard S. Geary","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039227038","display_name":"Brenda F. Baker","orcid":"https://orcid.org/0000-0001-8586-768X","observed_orcids":["https://orcid.org/0000-0001-8586-768X"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda F. Baker","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057710191","display_name":"Josephine Glover","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josephine M. Glover","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040437391","display_name":"Timothy Mant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy G.K. Mant","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002446366","display_name":"Rosie Z. Yu","orcid":"https://orcid.org/0000-0001-9266-7280","observed_orcids":["https://orcid.org/0000-0001-9266-7280"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosie Z. Yu","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112168600","display_name":"Joseph A. Tami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. Tami","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031039438","display_name":"F. Andrew Dorr","orcid":"https://orcid.org/0009-0004-7367-1419","observed_orcids":["https://orcid.org/0009-0004-7367-1419"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Andrew Dorr","raw_affiliation_strings":["1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.); and \n2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"1Isis Pharmaceuticals Inc., Carlsbad, California (K.L.S., R.S.G., B.F.B., J.M.G., R.Z.Y., J.A.T., F.A.D.)","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"2Guy's Drug Research Unit Ltd., London, United Kingdom (T.G.K.M.)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800035258"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":1.6253,"has_fulltext":false,"cited_by_count":122,"citation_normalized_percentile":{"value":0.82485859,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"303","issue":"3","first_page":"1334","last_page":"1343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.02319999970495701,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.8640000224113464},{"id":"https://openalex.org/keywords/phosphorothioate","display_name":"phosphorothioate","score":0.8489999771118164},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9169999957084656},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.5479999780654907},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8560000061988831},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.6890000104904175},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.871999979019165},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.9589999914169312},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4690000116825104},{"id":"https://openalex.org/keywords/dosing-interval","display_name":"dosing interval","score":0.5950000286102295},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6710728406906128},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.5596656203269958},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.539101243019104},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5362856388092041},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5336424112319946},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5198148488998413},{"id":"https://openalex.org/C2780043322","wikidata":"https://www.wikidata.org/wiki/Q2705359","display_name":"Phorbol","level":4,"score":0.5045663118362427},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4589240849018097},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4583356976509094},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3880288600921631},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36401131749153137},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3539985418319702},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.23718956112861633},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.173945814371109},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16098672151565552},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08866116404533386},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054735","descriptor_name":"Phosphorothioate Oligonucleotides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1124/jpet.102.036749","doi":"https://doi.org/10.1124/jpet.102.036749","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.102.036749","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:12438559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12438559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312060","display_name":"Francis Crick Institute","ror":"https://ror.org/04tnbqb63"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W80797884","https://openalex.org/W92700363","https://openalex.org/W352453586","https://openalex.org/W1891796305","https://openalex.org/W1946234531","https://openalex.org/W1961577685","https://openalex.org/W1970206786","https://openalex.org/W1983241347","https://openalex.org/W1985763670","https://openalex.org/W1988582067","https://openalex.org/W1992024544","https://openalex.org/W1996472975","https://openalex.org/W2028767896","https://openalex.org/W2036434973","https://openalex.org/W2036801946","https://openalex.org/W2058177171","https://openalex.org/W2070832716","https://openalex.org/W2083420496","https://openalex.org/W2093095283","https://openalex.org/W2098767548","https://openalex.org/W2145684092","https://openalex.org/W2155320970","https://openalex.org/W2255911290","https://openalex.org/W2314052274","https://openalex.org/W2317533048","https://openalex.org/W2319957449","https://openalex.org/W2321453230","https://openalex.org/W2326330820","https://openalex.org/W2336588424","https://openalex.org/W2340084730","https://openalex.org/W2340829617","https://openalex.org/W2431873939","https://openalex.org/W2480154911","https://openalex.org/W2486273739","https://openalex.org/W2491374885","https://openalex.org/W6815726140"],"related_works":["https://openalex.org/W2255911290","https://openalex.org/W26545631","https://openalex.org/W1983256944","https://openalex.org/W2147475770","https://openalex.org/W2189710711","https://openalex.org/W2024102230","https://openalex.org/W2248643920","https://openalex.org/W2065186743","https://openalex.org/W4206799643","https://openalex.org/W2208975888"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}